bioRxiv ScienceSearch

bioRxiv · 10.1101/491720

BOLD signal variability and complexity in children and adolescents with and without autism spectrum disorder

Abstract

Variability of neural signaling is an important index of healthy brain functioning, as is signal complexity, which relates to information processing capacity. It is thought that alterations in variability and complexity may underlie certain brain dysfunctions. Here, resting-state fMRI was used to examine brain signal variability and complexity in male children and adolescents with and without autism spectrum disorder (ASD), a highly heterogeneous neurodevelopmental disorder. Variability was measured using the mean square successive difference (MSSD) of the time series, and complexity of these time series was assessed using sample entropy. A categorical approach was implemented to determine if the brain measures differed between diagnostic groups (ASD and typically developing (TD) groups). A dimensional approach was used to examine the continuum of relationships between each brain measure and behavioural severity, age, IQ, and the global efficiency (GE) of each participants structural connectome, a metric that reflects the structural capacity for information processing. Using the categorical approach, no significant group differences were found for neither MSSD nor entropy. However, the dimensional approach revealed significant positive correlations between each brain measure, GE, and age. Further, negative correlations were observed between each brain measure and behavioural severity across all participants, whereby lower MSSD and entropy were associated with more severe ASD behaviours. These results reveal the nature of variability and complexity of fMRI signals in children and adolescents with and without ASD, and highlight the importance of taking a dimensional approach when analyzing brain function in ASD.\n\nSignificance statementIn this study, resting-state functional magnetic resonance imaging was used to examine the variability and complexity of brain signals in children and adolescents with and without autism spectrum disorder (ASD). Group differences were not observed in variability or complexity. However, there were significant associations between these measures, behavioural severity, age, and a measure of the brains capacity to perform information processing, called global efficiency. Variability and complexity were higher in older participants and in participants with higher global efficiency, but were lower in participants with more severe ASD behaviours. These results provide insight into two important components of brain function in children and adolescents with and without ASD.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Easson, A. K., McIntosh, A. R.. 2018-12-10. BOLD signal variability and complexity in children and adolescents with and without autism spectrum disorder. https://doi.org/10.1101/491720

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience